Does caffeine reduce rosuvastatin-induced protection against ischemia-reperfusion injury?
Phase of Trial: Phase II
Latest Information Update: 19 Aug 2009
At a glance
- Drugs Rosuvastatin (Primary) ; Caffeine
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 19 Aug 2009 Status changed from recruiting to completed.
- 01 Jun 2009 Results published in Arteriosclerosis Thrombosis and Vascular Biology.